Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Asks For “Restraint” On Drug Safety Worries
FDA Asks For “Restraint” On Drug Safety Worries
FDA Asks For “Restraint” On Drug Safety Worries
Submitted by
admin
on September 9, 2010 - 5:47pm
Source:
Forbes
News Tags:
FDA
drug safety
Vioxx
Avandia
Merck
Pfizer
GSK
Spiriva
Boehringer Ingelheim
Headline:
FDA Asks For “Restraint” On Drug Safety Worries
Do Not Allow Advertisers to Use My Personal information
